
China SXT Pharmaceuticals, Inc.
SXTCHealthcare|Drug Manufacturers - Specialty & Generic|CN
$2.83
-0.10 (-3.41%)
DCF Value
$3537.77
Tangible Book / Share
$5070.18
Cash / Share
$4809.87
Financing Filings (last 12 months)
7
Shelf registrations / offering prospectuses — latest Oct 9, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
Oct 22, 2026 · PRNewsWire
China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right
Oct 21, 2026 · PRNewsWire
Univest Securities, LLC Announces Closing of $12 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)
Oct 9, 2026 · Globe News Wire
China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering
Oct 8, 2026 · PRNewsWire
SEC Filings (42)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 21, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 15, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Oct 9, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 9, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Oct 8, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 8, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 16, 2026 | EFFECT | DocumentIndex | |
| Aug 28, 2026 | F-3/A | Shelf registration | DocumentIndex |
| Aug 28, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 24, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 24, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Jul 7, 2026 | F-3 | Shelf registration | DocumentIndex |
| Jul 6, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 1, 2026 | 20-F | Annual report (foreign) | DocumentIndex |
| Jun 1, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 1, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| May 4, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Apr 9, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Apr 9, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jan 13, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jan 12, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Dec 31, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Nov 14, 2025 | EFFECT | DocumentIndex | |
| Nov 10, 2025 | F-3 | Shelf registration | DocumentIndex |
| Nov 10, 2025 | POS AM | DocumentIndex | |
| Aug 7, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 7, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 7, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 7, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 31, 2025 | 20-F | Annual report (foreign) | DocumentIndex |
| Jul 29, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 15, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 16, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| May 19, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| May 13, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| May 7, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Mar 28, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Mar 28, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Mar 19, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Jan 27, 2025 | 6-K | Foreign issuer report | DocumentIndex |